Overview

DrugAbility is a drug target portfolio design & pharmacology strategic & technical consulting company revolutionizing AI-for-drug-discovery companies by directing smarter, more informed therapeutic drug target portfolio strategy. https://www.drugability.com/about *Directing drug target portfolio strategies and drug target selections for drug discovery companies to harness and leverage companies' unique technology "superpowers". *Technical drug target feasibility and safety assessments and drug target due diligence consulting. *Hit-to-lead project planning. *Consulted for Atomic AI - AI-for-RNA-structure-prediction-for-drug-discovery - to design their company's therapeutic strategy. Atomic AI's technology was featured on the cover of Science! https://www.linkedin.com/feed/update/urn:li:activity:6836733208223186944/ *Recent clients include insitro, Anagenex - a drug discovery company combining DNA-encoded libraries with machine learning, on designing their whole therapeutic drug target portfolio and drug portfolio strategy, internal pipeline, and drug target safety assessments - an AI Tech Company in the UK (confidential client), and a stealth-mode startup.